To the Editor.—
The article by Wexler et al entitled "The Vascular War of 1988"1 and the accompanying commentary by Dr Zarins2 call attention to an important problem that affects not only certain subspecialty practices, but, more important, patient welfare and medical costs. Wexler et al have made a forthright proposal to resolve the "turf battle" among vascular surgeons, radiologists, and cardiologists competing for rights to perform balloon or laser angioplasty or other new transluminal interventions. Their establishment of a Center for Interventional Vascular Therapies at the Stanford (Calif) University Medical Center should help arbitrate the conflicts. However, it skirts a more profound issue.Beyond the turf battle and who wins it lies the fundamental question of how to establish the indications for these new, appealing, and expensive interventions. This objective may not be met by the competing specialties themselves because of a conflict of interests. In view
Gurewich V. The Vascular War. JAMA. 1989;261(24):3550. doi:10.1001/jama.1989.03420240064019
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: